Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Canntab Therapeutics Ltd
CTABF
Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and...
consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:CTABF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1)
•••
Eppy
X
View Profile
View Bullboard History
Comment by
Eppy
on Jun 06, 2020 9:58am
RE:FSD Pharma Receives U.S. FDA Approval 💊🩹🎉
Is there a relationship between FSD and PILL?
(2135)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jun 02, 2020 11:29am
Deal with Medipharm
https://www.newswire.ca/news-releases/canntab-and-medipharm-labs-enter-into-a-wholesale-tablet-purchase-agreement-897979861.html
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(7)
•••
Chuckytoolucky
X
View Profile
View Bullboard History
Post by
Chuckytoolucky
on Jun 01, 2020 12:23pm
Halt
Hopefully this goes parabolic. thinking that it'll slowly gring upward. ok with that
(574)
•••
knoxt
X
View Profile
View Bullboard History
Post by
knoxt
on Jun 01, 2020 8:21am
Halt Trading
Canntab Therapeutics halted at 5:12 a.m. PT 2020-06-01 08:18 ET - Halt Trading Canntab Therapeutics Ltd. has been halted at 5:12 a.m. PT on June 1, 2020.
(0)
•••
fromBelgien
X
View Profile
View Bullboard History
Comment by
fromBelgien
on May 14, 2020 1:22pm
RE:RE:FSD building for sale 20 million.
it is moving! Beaming ! Uprising !
(0)
•••
fromBelgien
X
View Profile
View Bullboard History
Comment by
fromBelgien
on Apr 28, 2020 12:14pm
RE:FSD building for sale 20 million.
https://instagram.com/canntabtherapeutics?igshid=15bf6zigxh4em
(0)
•••
fromBelgien
X
View Profile
View Bullboard History
Comment by
fromBelgien
on Apr 28, 2020 12:13pm
RE:FSD building for sale 20 million.
https://instagram.com/canntabtherapeutics?igshid=15bf6zigxh4em
(0)
•••
fromBelgien
X
View Profile
View Bullboard History
Comment by
fromBelgien
on Apr 28, 2020 10:40am
RE:FSD building for sale 20 million.
Canntab is in full production !
(6)
•••
Bigboypants
X
View Profile
View Bullboard History
Post by
Bigboypants
on Apr 21, 2020 1:19pm
FSD building for sale 20 million.
Where are there going to make there Pills, outside in the parking lot.
(10)
•••
AnalogueMan
X
View Profile
View Bullboard History
Post by
AnalogueMan
on Mar 04, 2020 10:08am
Bit of a POP today on news of licence ... ~10%
VANCOUVER, BC / ACCESSWIRE / March 3, 2020 / World-Class Extractions Inc. (CSE:PUMP) (FRA:WCF)(OTCQB:WCEXF) (the "Company" or "World-Class"), an innovation-driven company that
...more
(0)
•••
fromBelgien
X
View Profile
View Bullboard History
Comment by
fromBelgien
on Feb 23, 2020 4:37pm
RE:RE:Halted. Did they finally get HC approval for the tablets?
must be greater when if sales license comes together with LP
(5)
•••
Mellymelrascal
X
View Profile
View Bullboard History
Comment by
Mellymelrascal
on Feb 22, 2020 9:11pm
RE:Halted. Did they finally get HC approval for the tablets?
Possible health Canada LP license approval as per post below, they submitted over 2 months ago the paperwork.
(4)
•••
Mindfull
X
View Profile
View Bullboard History
Post by
Mindfull
on Feb 21, 2020 3:32pm
Halted. Did they finally get HC approval for the tablets?
Any other idea why PILL is haulted?
(2135)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Feb 06, 2020 4:00pm
RE:Fins on sedar
As predicted, PP launched.... Canntab Therapeutics For Immediate Release 2020_02_06 CANNTAB ANNOUNCES NON-BROKERED PRIVATE PLACEMENT TORONTO, February 6th
...more
(0)
•••
fromBelgien
X
View Profile
View Bullboard History
Comment by
fromBelgien
on Feb 03, 2020 7:59am
RE:Sold my xly and ish yesterday bought in at 1.37
?? Dear investor Here you are on board of Canntab therapeutics!
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >